Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $570.37M | $311.79M | +82.94% |
Operating Income | $-130.46M | $-586.77M | +77.77% |
Net Income | $-110.88M | $-616.96M | +82.03% |
EPS (Basic) | $-0.64 | $-9.02 | +92.90% |
EPS (Diluted) | $-0.64 | $-9.02 | +92.90% |
R&D Expense | $77.49M | $92.36M | -16.10% |
SG&A Expense | $335.34M | $542.64M | -38.20% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.63B | $864.61M | +87.99% |
Current Assets | $644.2M | $671.37M | -4.05% |
Total Liabilities | $1.32B | $766.36M | +71.70% |
Current Liabilities | $418.16M | $181.56M | +130.31% |
Stockholders' Equity | $309.56M | $98.25M | +215.07% |
Cash & Equivalents | $186.31M | $478.81M | -61.09% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-61.46M | $-198.46M | +69.03% |
Investing Cash Flow | $-385.33M | $8.98M | -4390.01% |
Financing Cash Flow | $293.04M | $502.63M | -41.70% |
Dividends Paid | $0 | $5.63M | -100.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -22.9% | -188.2% | +165.32% |
Net Margin | -19.4% | — | — |
ROE | -35.8% | — | — |
ROA | -6.8% | — | — |
Current Ratio | $1.541 | — | — |
Debt to Equity | $4.251 | — | — |
Other companies in Life Sciences Tools & Services